1. Home
  2. CGEM vs SHBI Comparison

CGEM vs SHBI Comparison

Compare CGEM & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • SHBI
  • Stock Information
  • Founded
  • CGEM 2016
  • SHBI 1876
  • Country
  • CGEM United States
  • SHBI United States
  • Employees
  • CGEM N/A
  • SHBI N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • SHBI Major Banks
  • Sector
  • CGEM Health Care
  • SHBI Finance
  • Exchange
  • CGEM Nasdaq
  • SHBI Nasdaq
  • Market Cap
  • CGEM 490.3M
  • SHBI 415.6M
  • IPO Year
  • CGEM 2021
  • SHBI N/A
  • Fundamental
  • Price
  • CGEM $7.54
  • SHBI $14.58
  • Analyst Decision
  • CGEM Strong Buy
  • SHBI Buy
  • Analyst Count
  • CGEM 4
  • SHBI 2
  • Target Price
  • CGEM $33.50
  • SHBI $20.00
  • AVG Volume (30 Days)
  • CGEM 457.5K
  • SHBI 144.8K
  • Earning Date
  • CGEM 05-08-2025
  • SHBI 04-29-2025
  • Dividend Yield
  • CGEM N/A
  • SHBI 3.31%
  • EPS Growth
  • CGEM N/A
  • SHBI 241.50
  • EPS
  • CGEM N/A
  • SHBI 1.48
  • Revenue
  • CGEM N/A
  • SHBI $201,667,000.00
  • Revenue This Year
  • CGEM N/A
  • SHBI N/A
  • Revenue Next Year
  • CGEM N/A
  • SHBI $8.55
  • P/E Ratio
  • CGEM N/A
  • SHBI $9.89
  • Revenue Growth
  • CGEM N/A
  • SHBI 37.93
  • 52 Week Low
  • CGEM $6.85
  • SHBI $10.36
  • 52 Week High
  • CGEM $30.19
  • SHBI $17.61
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.51
  • SHBI 66.77
  • Support Level
  • CGEM $7.50
  • SHBI $14.26
  • Resistance Level
  • CGEM $8.97
  • SHBI $14.84
  • Average True Range (ATR)
  • CGEM 0.48
  • SHBI 0.39
  • MACD
  • CGEM -0.04
  • SHBI 0.20
  • Stochastic Oscillator
  • CGEM 2.72
  • SHBI 92.37

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in two business segments - community banking and mortgage banking. Community banking is conducted through the Bank and involves delivering a broad range of financial services, including lending and deposit-taking, to individuals and commercial enterprises, it also includes treasury and administrative functions. Mortgage banking is conducted through the Bank's secondary marketing department and involves originating first and second-lien residential mortgages for sale in the secondary market.

Share on Social Networks: